Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

499.40
-0.3100-0.06%
Post-market: 499.400.00000.00%19:30 EDT
Volume:289.23K
Turnover:143.75M
Market Cap:11.51B
PE:-35.13
High:505.00
Open:505.00
Low:491.05
Close:499.71
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.24
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:21.98
PE(LYR):-38.86

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)

TIPRANKS
·
Jul 14

Madrigal Pharmaceuticals' Three New Patents Support Patent Extension Into 2045, Truist Says

MT Newswires Live
·
Jul 14

Madrigal Wins Three New US Patents for MASH Drug Rezdiffra, Boosting IP Protection

Reuters
·
Jul 13

Madrigal Grants New Hires 604 Stock Options, 2,952 Restricted Stock Units Under Inducement Plan

Reuters
·
Jul 07

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 07

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 07

Will Madrigal’s New siRNA MASH Candidate Shift Madrigal Pharmaceuticals' (MDGL) Rezdiffra-Centric Narrative

Simply Wall St.
·
Jul 04

Suzhou Ribo Hits First Milestone in Madrigal Sirna Collaboration for MASH Drug Candidate

Reuters
·
Jul 02

Medicare Coverage Could Put These Obesity Drug Stocks In Focus

Simply Wall St.
·
Jun 30

Madrigal Pharmaceuticals grants 1,397 inducement RSUs to five new employees under 2025 plan

Reuters
·
Jun 23

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 23

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 23

Madrigal Pharmaceuticals adopts nonqualified deferred compensation plan effective Aug. 1

Reuters
·
Jun 18

Madrigal Pharmaceuticals Is Maintained at Neutral by B of A Securities

Dow Jones
·
Jun 11

BofA Securities Adjusts Madrigal Pharmaceuticals Price Target to $542 From $550

MT Newswires Live
·
Jun 11

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After New Rezdiffra Data And Analyst Upgrades

Simply Wall St.
·
Jun 06

Madrigal grants 6,881 inducement RSUs to 20 new employees under 2025 plan

Reuters
·
Jun 05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Madrigal Pharmaceuticals (MDGL) Is Down 7.5% After New Rezdiffra MASH Cardiometabolic Data Release – Has The Bull Case Changed?

Simply Wall St.
·
Jun 04